Cited 4 time in
Catheter-Related Bladder Discomfort: How Can We Manage It?
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jang, Eun Bi | - |
| dc.contributor.author | Hong, Seong Hwi | - |
| dc.contributor.author | Kim, Kyu Shik | - |
| dc.contributor.author | Park, Sung Yul | - |
| dc.contributor.author | Kim, Yong Tae | - |
| dc.contributor.author | Yoon, Young Eun | - |
| dc.contributor.author | Moon, Hong Sang | - |
| dc.date.accessioned | 2022-07-07T02:37:22Z | - |
| dc.date.available | 2022-07-07T02:37:22Z | - |
| dc.date.issued | 2020-12 | - |
| dc.identifier.issn | 2093-4777 | - |
| dc.identifier.issn | 2093-6931 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/142585 | - |
| dc.description.abstract | The urethral catheter is used in various clinical situations such as diagnosing urologic disease, urine drainage in patients after surgery, and for patients who cannot urinate voluntarily. However, catheters can cause numerous adverse effects, such as catheter-associated infection, obstruction, bladder stones, urethral injury, and catheter-related bladder discomfort (CRBD). CRBD symptoms vary among patients from burning sensation and pain in the suprapubic and penile areas to urinary urgency CRBD significantly reduces patient quality of life and can lead to several complications. CRBD is caused by catheter-induced bladder irritation due to muscarinic receptor-mediated involuntary contractions of bladder smooth muscle and also can be caused by mechanical stimulus of the urethral catheter. Various pharmacologic studies for managing CRBD, including antimuscarinic and anti-epileptic agents and botulinum toxin injections have been reported. If urologists can reduce patients' CRBD, their quality of life and recovery can improve. | - |
| dc.format.extent | 8 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | KOREAN CONTINENCE SOC | - |
| dc.title | Catheter-Related Bladder Discomfort: How Can We Manage It? | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.5213/inj.2040108.054 | - |
| dc.identifier.scopusid | 2-s2.0-85100099654 | - |
| dc.identifier.wosid | 000604618400004 | - |
| dc.identifier.bibliographicCitation | INTERNATIONAL NEUROUROLOGY JOURNAL, v.24, no.4, pp 324 - 331 | - |
| dc.citation.title | INTERNATIONAL NEUROUROLOGY JOURNAL | - |
| dc.citation.volume | 24 | - |
| dc.citation.number | 4 | - |
| dc.citation.startPage | 324 | - |
| dc.citation.endPage | 331 | - |
| dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
| dc.identifier.kciid | ART002668886 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Urology & Nephrology | - |
| dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
| dc.subject.keywordPlus | IDIOPATHIC OVERACTIVE BLADDER | - |
| dc.subject.keywordPlus | NEUROGENIC DETRUSOR OVERACTIVITY | - |
| dc.subject.keywordPlus | TRANSURETHRAL RESECTION | - |
| dc.subject.keywordPlus | MUSCARINIC RECEPTOR | - |
| dc.subject.keywordPlus | CLINICAL-EFFICACY | - |
| dc.subject.keywordPlus | URINARY-TRACT | - |
| dc.subject.keywordPlus | PREVENTION | - |
| dc.subject.keywordPlus | TOLTERODINE | - |
| dc.subject.keywordPlus | SOLIFENACIN | - |
| dc.subject.keywordPlus | PLACEBO | - |
| dc.subject.keywordAuthor | Urinary catheter | - |
| dc.subject.keywordAuthor | Urinary bladder | - |
| dc.subject.keywordAuthor | Muscarinic antagonist | - |
| dc.identifier.url | https://www.einj.org/journal/view.php?doi=10.5213/inj.2040108.054 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
